Antibacterial lipopeptide shown to be highly effective in killing Staphylococcus aureus

FHS
June 6, 2024
4:39 pm

A novel antibacterial lipopeptide produced by the bacterium Serratia marcescens has been shown to be highly effective in killing Staphylococcus aureus – one of the most important pathogens occurring in humans.

Coherus to buy Surface Oncology in stock deal valued at $65M

Coherus BioSciences is making a small stock-for-stock transaction to shore up its immuno-oncology pipeline in an acquisition of Surface Oncology that is valued at $65

June 17, 2023

High-fat diet changes gut bacteria, bile acids, and increases colorectal cancer risk

The prevalence of colorectal cancer in people under the age of 50 has risen in recent decades. One suspected reason: the increasing rate of obesity

August 22, 2023

Essence Healthcare to Offer Free Oura Ring to Medicare Advantage Members

What You Should Know: – Essence Healthcare, a provider of Medicare Advantage (MA) plans forms a new partnership with ŌURA, the maker of the Oura

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.